Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Times Interest Earned (2022 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Times Interest Earned for 4 consecutive years, with -$10.2 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned fell 34.64% to -$10.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.33 through Dec 2025, up 29.56% year-over-year, with the annual reading at -$9.33 for FY2025, 27.61% up from the prior year.
  • Times Interest Earned for Q4 2025 was -$10.2 at Rhythm Pharmaceuticals, up from -$11.1 in the prior quarter.
  • The five-year high for Times Interest Earned was -$7.57 in Q4 2024, with the low at -$980.35 in Q2 2022.
  • Average Times Interest Earned over 4 years is -$77.26, with a median of -$11.1 recorded in 2025.
  • The sharpest move saw Times Interest Earned surged 98.56% in 2023, then plummeted 71.43% in 2024.
  • Over 4 years, Times Interest Earned stood at -$13.98 in 2022, then surged by 35.14% to -$9.07 in 2023, then rose by 16.49% to -$7.57 in 2024, then plummeted by 34.64% to -$10.2 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$10.2, -$11.1, and -$7.79 for Q4 2025, Q3 2025, and Q2 2025 respectively.